CA2577567C - Hemofiltration a deux phases generant un fluide de remplacement - Google Patents

Hemofiltration a deux phases generant un fluide de remplacement Download PDF

Info

Publication number: CA2577567C
Authority: CA; Canada
Prior art keywords: blood; filtration; patient; rotor; replacement fluid
Prior art date: 2004-08-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA2577567A

Other languages

English (en)

Other versions

CA2577567A1 (fr

Inventor

Don Schoendorfer

Jennifer K. Mclaughlin

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

KKJ Inc

Original Assignee

KKJ Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-20

Filing date

2004-08-20

Publication date

2010-01-26

2004-08-20 Application filed by KKJ Inc filed Critical KKJ Inc

2006-03-02 Publication of CA2577567A1 publication Critical patent/CA2577567A1/fr

2010-01-26 Application granted granted Critical

2010-01-26 Publication of CA2577567C publication Critical patent/CA2577567C/fr

2024-08-20 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

239000012530 fluid Substances 0.000 title claims abstract description 113
238000002615 hemofiltration Methods 0.000 title description 10
210000004369 blood Anatomy 0.000 claims abstract description 175
239000008280 blood Substances 0.000 claims abstract description 175
238000001914 filtration Methods 0.000 claims abstract description 169
239000002699 waste material Substances 0.000 claims abstract description 92
238000000502 dialysis Methods 0.000 claims abstract description 76
239000000047 product Substances 0.000 claims abstract description 47
239000000706 filtrate Substances 0.000 claims abstract description 22
239000012528 membrane Substances 0.000 claims description 65
230000017531 blood circulation Effects 0.000 claims description 24
230000000153 supplemental effect Effects 0.000 claims description 9
239000000654 additive Substances 0.000 claims description 6
239000003146 anticoagulant agent Substances 0.000 claims description 6
229940127219 anticoagulant drug Drugs 0.000 claims description 6
230000036770 blood supply Effects 0.000 claims description 5
230000000996 additive effect Effects 0.000 claims 2
210000004379 membrane Anatomy 0.000 description 48
238000001631 haemodialysis Methods 0.000 description 43
230000000322 hemodialysis Effects 0.000 description 43
238000000034 method Methods 0.000 description 37
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 30
238000000108 ultra-filtration Methods 0.000 description 20
239000003792 electrolyte Substances 0.000 description 13
230000010287 polarization Effects 0.000 description 13
235000015097 nutrients Nutrition 0.000 description 12
239000000306 component Substances 0.000 description 10
239000000243 solution Substances 0.000 description 9
238000012546 transfer Methods 0.000 description 9
230000008901 benefit Effects 0.000 description 8
239000000385 dialysis solution Substances 0.000 description 7
231100000331 toxic Toxicity 0.000 description 7
230000002588 toxic effect Effects 0.000 description 7
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
230000006870 function Effects 0.000 description 6
239000000463 material Substances 0.000 description 6
230000008569 process Effects 0.000 description 6
239000003053 toxin Substances 0.000 description 6
231100000765 toxin Toxicity 0.000 description 6
108700012359 toxins Proteins 0.000 description 6
210000004027 cell Anatomy 0.000 description 5
210000003734 kidney Anatomy 0.000 description 5
238000009987 spinning Methods 0.000 description 5
239000006227 byproduct Substances 0.000 description 4
239000000470 constituent Substances 0.000 description 4
238000009792 diffusion process Methods 0.000 description 4
239000007788 liquid Substances 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
238000012545 processing Methods 0.000 description 4
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
229910019142 PO4 Inorganic materials 0.000 description 3
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
230000000712 assembly Effects 0.000 description 3
238000000429 assembly Methods 0.000 description 3
239000000872 buffer Substances 0.000 description 3
239000011575 calcium Substances 0.000 description 3
229910052791 calcium Inorganic materials 0.000 description 3
239000008121 dextrose Substances 0.000 description 3
230000000694 effects Effects 0.000 description 3
239000008103 glucose Substances 0.000 description 3
239000011777 magnesium Substances 0.000 description 3
229910052749 magnesium Inorganic materials 0.000 description 3
239000000203 mixture Substances 0.000 description 3
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
239000010452 phosphate Substances 0.000 description 3
239000011591 potassium Substances 0.000 description 3
229910052700 potassium Inorganic materials 0.000 description 3
238000000926 separation method Methods 0.000 description 3
150000003384 small molecules Chemical class 0.000 description 3
239000011734 sodium Substances 0.000 description 3
229910052708 sodium Inorganic materials 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
238000013459 approach Methods 0.000 description 2
210000001367 artery Anatomy 0.000 description 2
238000010923 batch production Methods 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
210000000601 blood cell Anatomy 0.000 description 2
230000036760 body temperature Effects 0.000 description 2
238000004891 communication Methods 0.000 description 2
230000007423 decrease Effects 0.000 description 2
230000009977 dual effect Effects 0.000 description 2
230000004907 flux Effects 0.000 description 2
239000002920 hazardous waste Substances 0.000 description 2
239000008241 heterogeneous mixture Substances 0.000 description 2
230000006872 improvement Effects 0.000 description 2
230000004941 influx Effects 0.000 description 2
208000017169 kidney disease Diseases 0.000 description 2
239000002245 particle Substances 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
238000004064 recycling Methods 0.000 description 2
238000012958 reprocessing Methods 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
239000013535 sea water Substances 0.000 description 2
239000000126 substance Substances 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
210000003462 vein Anatomy 0.000 description 2
239000002351 wastewater Substances 0.000 description 2
241000208140 Acer Species 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
244000286663 Ficus elastica Species 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
244000046052 Phaseolus vulgaris Species 0.000 description 1
235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
240000000111 Saccharum officinarum Species 0.000 description 1
235000007201 Saccharum officinarum Nutrition 0.000 description 1
210000000683 abdominal cavity Anatomy 0.000 description 1
230000003187 abdominal effect Effects 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
239000012503 blood component Substances 0.000 description 1
238000010261 blood fractionation Methods 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
230000001112 coagulating effect Effects 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
238000011109 contamination Methods 0.000 description 1
238000010924 continuous production Methods 0.000 description 1
238000011973 continuous veno-venous hemofiltration Methods 0.000 description 1
239000008162 cooking oil Substances 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
239000008151 electrolyte solution Substances 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
238000000605 extraction Methods 0.000 description 1
235000013305 food Nutrition 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
239000012510 hollow fiber Substances 0.000 description 1
239000012535 impurity Substances 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
239000010687 lubricating oil Substances 0.000 description 1
239000006166 lysate Substances 0.000 description 1
238000009115 maintenance therapy Methods 0.000 description 1
239000002906 medical waste Substances 0.000 description 1
238000009285 membrane fouling Methods 0.000 description 1
230000006371 metabolic abnormality Effects 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
230000002969 morbid Effects 0.000 description 1
239000010705 motor oil Substances 0.000 description 1
210000003516 pericardium Anatomy 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
230000035699 permeability Effects 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
238000003672 processing method Methods 0.000 description 1
238000000746 purification Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000007873 sieving Methods 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
239000000758 substrate Substances 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
239000013589 supplement Substances 0.000 description 1
239000008399 tap water Substances 0.000 description 1
235000020679 tap water Nutrition 0.000 description 1
239000010891 toxic waste Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1694—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid
- A61M1/1696—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid with dialysate regeneration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/26—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes and internal elements which are moving
- A61M1/262—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes and internal elements which are moving rotating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/26—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes and internal elements which are moving
- A61M1/262—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes and internal elements which are moving rotating
- A61M1/265—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes and internal elements which are moving rotating inducing Taylor vortices
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
- A61M1/3455—Substitution fluids
- A61M1/3468—Substitution fluids using treated filtrate as substitution fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A61M1/3482—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate by filtrating the filtrate using another cross-flow filter, e.g. a membrane filter
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D65/00—Accessories or auxiliary operations, in general, for separation processes or apparatus using semi-permeable membranes
- B01D65/08—Prevention of membrane fouling or of concentration polarisation
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2321/00—Details relating to membrane cleaning, regeneration, sterilization or to the prevention of fouling
- B01D2321/20—By influencing the flow
- B01D2321/2033—By influencing the flow dynamically

Landscapes

Health & Medical Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Anesthesiology (AREA)
Veterinary Medicine (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Chemical & Material Sciences (AREA)
External Artificial Organs (AREA)
Separation Using Semi-Permeable Membranes (AREA)

CA2577567A 2004-08-20 2004-08-20 Hemofiltration a deux phases generant un fluide de remplacement Expired - Fee Related CA2577567C (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2004/027305 WO2006022737A1 (fr)	2004-08-20	2004-08-20	Hémofiltration à deux phases générant un fluide de remplacement

Publications (2)

Publication Number	Publication Date
CA2577567A1 CA2577567A1 (fr)	2006-03-02
CA2577567C true CA2577567C (fr)	2010-01-26

Family

ID=34958696

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2577567A Expired - Fee Related CA2577567C (fr)	2004-08-20	2004-08-20	Hemofiltration a deux phases generant un fluide de remplacement

Country Status (5)

Country	Link
EP (1)	EP1791580A1 (fr)
JP (1)	JP4964133B2 (fr)
AU (1)	AU2004322685B2 (fr)
CA (1)	CA2577567C (fr)
WO (1)	WO2006022737A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102009026901A1 (de)	2009-06-10	2010-12-16	Fresenius Medical Care Deutschland Gmbh	Dialysevorrichtung
CN108773947A (zh) *	2018-05-30	2018-11-09	四川奥恒环保科技有限公司	一种污水处理装置

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3619423A (en) *	1970-04-20	1971-11-09	Us Health Education & Welfare	Cascade dialysis apparatus and method
US4230564A (en) *	1978-07-24	1980-10-28	Keefer Bowie	Rotary reverse osmosis apparatus and method
US5034135A (en)	1982-12-13	1991-07-23	William F. McLaughlin	Blood fractionation system and method
GB8327911D0 (en)	1983-10-19	1983-11-23	Ciba Geigy Ag	Salts as corrosion inhibitors
WO1985004112A1 (fr)	1984-03-21	1985-09-26	Mclaughlin, William, Francis	Procede et appareil de filtrage
JPS60200900A (ja)	1984-03-26	1985-10-11	Sumitomo Electric Ind Ltd	低転位密度の３−５化合物半導体単結晶
US4675106A (en)	1985-04-12	1987-06-23	Hemascience Laboratories, Inc.	Pivot pin bearing for biomedical systems
US4816151A (en)	1985-04-26	1989-03-28	Baxter International Inc.	Rotor drive for medical disposables
US4753729A (en)	1985-04-26	1988-06-28	Baxter Travenol Laboratories, Inc.	Rotor drive for medical disposables
US4871462A (en) *	1985-12-23	1989-10-03	Haemonetics Corporation	Enhanced separation of blood components
DE3772749D1 (de) *	1986-08-11	1991-10-10	Baxter Int	Waschsystem von blutzellen und verfahren.
JPH01249062A (ja) *	1988-03-29	1989-10-04	Sekisui Chem Co Ltd	体外循環回路
IT1241588B (it) *	1990-03-09	1994-01-19	Sorin Biomedica Emodialisi S R	Apparecchiatura per la depurazione del sangue, particolarmente per il trattamento di pazienti affetti da insufficienza renale, e procedimentoo per produzione di liquido di reinfusione per emodiafiltrazione (hdf)
DE4224963A1 (de) *	1991-01-30	1994-02-03	Schurek Hans Joachim Prof Dr M	Hämodialyse
DE4102693A1 (de) *	1991-01-30	1992-08-06	Schurek Hans Joachim Prof Dr M	Verfahren und einrichtung zur haemofiltratdialyse
JP3353467B2 (ja) *	1994-05-27	2002-12-03	ニプロ株式会社	血液透析装置の透析液管理装置
JP3608745B2 (ja) *	1994-08-11	2005-01-12	旭化成メディカル株式会社	体液処理装置
AU2069695A (en) *	1995-03-13	1996-10-02	Ao Forschungsinstitut Davos	An extracorporeal blood treatment apparatus and method for removal of free circulating infectious agents
JPH1071201A (ja) *	1996-01-19	1998-03-17	Terumo Corp	血液浄化排液再生装置、血液浄化液回路および血液浄化装置
JP2000107282A (ja) *	1998-10-06	2000-04-18	Kuraray Co Ltd	血液処理用装置
US7241272B2 (en) *	2001-11-13	2007-07-10	Baxter International Inc.	Method and composition for removing uremic toxins in dialysis processes
US6863821B2 (en) *	2002-02-02	2005-03-08	Baxter International Inc.	Shear-enhanced systems and methods for removing waste materials and liquid from the blood

2004
- 2004-08-20 CA CA2577567A patent/CA2577567C/fr not_active Expired - Fee Related
- 2004-08-20 WO PCT/US2004/027305 patent/WO2006022737A1/fr not_active Ceased
- 2004-08-20 JP JP2007527177A patent/JP4964133B2/ja not_active Expired - Fee Related
- 2004-08-20 EP EP04781905A patent/EP1791580A1/fr not_active Withdrawn
- 2004-08-20 AU AU2004322685A patent/AU2004322685B2/en not_active Ceased

Also Published As

Publication number	Publication date
EP1791580A1 (fr)	2007-06-06
CA2577567A1 (fr)	2006-03-02
JP2008510511A (ja)	2008-04-10
WO2006022737A1 (fr)	2006-03-02
AU2004322685A1 (en)	2006-03-02
JP4964133B2 (ja)	2012-06-27
AU2004322685B2 (en)	2009-04-23

Legal Events

Date	Code	Title	Description
2007-02-19	EEER	Examination request
2015-10-01	MKLA	Lapsed	Effective date: 20150820

Publication	Publication Date	Title
US7531094B2 (en)	2009-05-12	Two stage hemofiltration that generates replacement fluid
US20070193941A1 (en)	2007-08-23	Vortex-enhanced filtration devices
KR100604460B1 (ko)	2006-07-26	혈액 투석여과/혈액 여과 카트리지
JP5106102B2 (ja)	2012-12-26	代謝的無毒化システムおよび方法
US6582385B2 (en)	2003-06-24	Hemofiltration system including ultrafiltrate purification and re-infusion system
CN101269246A (zh)	2008-09-24	一种带置换液净化器的连续血液净化设备
US3788319A (en)	1974-01-29	System for exchanging blood ultrafiltrate
CN201186074Y (zh)	2009-01-28	带置换液净化器的连续血液净化设备
CA2577567C (fr)	2010-01-26	Hemofiltration a deux phases generant un fluide de remplacement
MX2011012927A (es)	2012-01-30	Dispositivo de dialisis.
CN108697987B (zh)	2021-03-30	用于过滤流体的系统和方法
US9757504B2 (en)	2017-09-12	Systems and methods for performing hemodialysis
CN110769920B (zh)	2022-02-22	用于过滤和/或稀释流体的系统和方法